专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明申请

US20070215879A1 Opto-electronic devices exhibiting enhanced efficiency 审中-公开
标题翻译：表现出提高效率的光电器件
公开(公告)号：US20070215879A1
公开(公告)日：2007-09-20
申请号：US11384769
申请日：2006-03-20
申请人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
发明人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
IPC分类号： H01L33/00 , C09K9/00
CPC分类号： C09K9/02 , C09K2211/1007 , C09K2211/1014 , C09K2211/1044 , H01G9/2059 , H01L51/4206 , H01L51/5032 , H01L51/5221 , Y02E10/542
摘要： Described herein is an organic opto-electronic device comprising a cathode comprising at least one zero-valent metal; an anode; an opto-electronically active organic material; wherein said cathode is in contact with at least one organic ammonium salt. In certain embodiments, the organic ammonium salt has structure (I) wherein R1-R4 are independently at each occurrence a C1-C20 aliphatic radical, a C3-C20 cycloaliphatic radical, or a C3-C20 aromatic radical is disclosed and wherein X+ is selected from the group consisting of monovalent inorganic anions, monovalent organic anions, polyvalent inorganic anions, polyvalent organic anions, and mixtures thereof.
摘要翻译：本文描述的是一种有机光电子器件，其包括：包含至少一种零价金属的阴极; 阳极; 光电活性有机材料; 其中所述阴极与至少一种有机铵盐接触。在某些实施方案中，有机铵盐具有结构（I），其中R 1至R 4各自独立地为C 1 -C 3 20脂肪族基团，C 3 -C 20脂环族基团或C 3 -C 20脂肪族基团， 20芳族基团，其中X +选自一价无机阴离子，一价有机阴离子，多价无机阴离子，多价有机阴离子及其混合物。

52. 外观设计

USD999833S1 Bubble machine 有权
公开(公告)号：USD999833S1
公开(公告)日：2023-09-26
申请号：US29885564
申请日：2023-02-27
申请人： Qing Ye
设计人： Qing Ye
摘要： FIG. 1 is a top perspective view of a bubble machine showing my new design;
FIG. 2 is a bottom perspective view thereof;
FIG. 3 is a right perspective view thereof;
FIG. 4 is a front elevation view thereof;
FIG. 5 is a left side elevation view thereof;
FIG. 6 is a right side elevation view thereof;
FIG. 7 is a top plan view thereof;
FIG. 8 is a bottom plan view thereof;
FIG. 9 is a partial enlarged view of FIG. 4; and,
FIG. 10 is a partial enlarged view of FIG. 8.
Broken lines in the drawings depict portions of the bubble machine that form no part of the claimed design. The additional broken lines surrounding the detail views are for annotative purposes only and form no part thereof.

53. 发明申请

US20120214807A1 COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 审中-公开
标题翻译：化合物作为CCR2的拮抗剂有用
公开(公告)号：US20120214807A1
公开(公告)日：2012-08-23
申请号：US13281482
申请日：2011-10-26
申请人： Shomir Ghosh , Prakash Raman , Kevin Sprott , Amy M. Elder , Sian Griffiths , Francois Soucy , Qing Ye
发明人： Shomir Ghosh , Prakash Raman , Kevin Sprott , Amy M. Elder , Sian Griffiths , Francois Soucy , Qing Ye
IPC分类号： A61K31/5377 , A61K31/517 , A61K31/435 , A61K31/4725 , A61K31/454 , A61K31/453 , A61K31/4439 , C07D471/04 , C07D405/14 , C07D413/14 , C07D405/04 , C07D409/14 , A61P29/00 , A61P19/02 , A61P25/00 , A61P9/10 , A61P3/10 , A61K31/5025
CPC分类号： C07D401/06 , C07D401/14 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14 , C07D471/04
摘要： The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
摘要翻译：本发明提供通式I的化合物或其药学上可接受的盐，其中X，n，Y和R 1通常在本文中定义并在亚组中。本发明的化合物是CCR2的抑制剂，因此可用于治疗各种炎症，过敏和自身免疫疾病，病症或病症。

54. 发明申请

US20110190272A1 CHEMICAL COMPOUNDS 审中-公开
标题翻译：化学化合物
公开(公告)号：US20110190272A1
公开(公告)日：2011-08-04
申请号：US12990711
申请日：2009-05-06
申请人： Kevin Daly , Del Valle David , David Scott , Qing Ye
发明人： Kevin Daly , Del Valle David , David Scott , Qing Ye
IPC分类号： A61K31/551 , C07D237/28 , A61K31/502 , C07D403/12 , C07D401/12 , C07D413/12 , A61K31/5377 , A61P35/00
CPC分类号： C07D403/04 , C07D237/28 , C07D401/04 , C07D417/04 , C07D487/04
摘要： The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof which possess CSF-IR kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
摘要翻译：本发明涉及具有CSF-1R激酶抑制活性的式（I）化合物或其药学上可接受的盐，因此可用于其抗癌活性，因此可用于治疗人或动物体的方法。本发明还涉及制备所述化合物的方法，含有它们的药物组合物及其在制造用于在温血动物如人中产生抗癌作用的药物中的用途。

55. 发明授权

US07989476B2 Electron-transporting materials and processes for making the same 有权
标题翻译：电子传输材料及其制造方法
公开(公告)号：US07989476B2
公开(公告)日：2011-08-02
申请号：US12350629
申请日：2009-01-08
申请人： Kelly Scott Chichak , Qing Ye , Yangang Liang , Shengxia Liu , Rui Wang
发明人： Kelly Scott Chichak , Qing Ye , Yangang Liang , Shengxia Liu , Rui Wang
IPC分类号： A01N43/40 , C07D213/04
CPC分类号： C07D213/16 , C07D213/53
摘要： Compound of formula C is made by reacting a compound of formula A with an pyridyl boronic acid or pyridyl borate ester to form a compound of formula B; and combining the compound of formula B with a pyridyl dihalide to form the compound of C; wherein R3, R4, R5, R6 and R7 are, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; X is, independently at each occurrence, CH or N; Y is chloro or bromo; Z is bromo or iodo; and when Y is bromo, Z is iodo; d, e, and g are, independently at each occurrence, an integer ranging from 0-4; f is an integer ranging from 0-2; and h is an integer ranging from 0-3.
摘要翻译：式C化合物通过使式A的化合物与吡啶基硼酸或吡啶基硼酸酯反应形成式B的化合物而制备; 并将式B化合物与吡啶基二卤化物结合形成C的化合物; 其中R 3，R 4，R 5，R 6和R 7在每次出现时独立地为C 1 -C 20脂族基团，C 3 -C 20芳族基团或C 3 -C 20脂环族基团; 每次出现时，X独立地为CH或N; Y是氯或溴; Z是溴或碘; 当Y为溴时，Z为碘; d，e和g各自独立地为0-4的整数; f是0-2的整数; h为0-3的整数。

56. 发明授权

US07932336B2 Tulipalin copolymers 有权
标题翻译：杜鹃花素共聚物
公开(公告)号：US07932336B2
公开(公告)日：2011-04-26
申请号：US12277373
申请日：2008-11-25
申请人： James Pickett , Qing Ye , Daniel Steiger
发明人： James Pickett , Qing Ye , Daniel Steiger
IPC分类号： C08F134/02
CPC分类号： B32B27/08 , B32B27/18 , B32B27/365 , B32B2270/00 , B32B2398/10 , B32B2398/20 , Y10T428/31507 , Y10T428/31663 , Y10T428/31667 , Y10T428/31855 , Y10T428/31909 , Y10T428/31928 , Y10T428/31931 , Y10T428/31935
摘要： Copolymers are disclosed comprising structural units derived from α-methylene-γ-butyrolactone, styrene, methyl methacrylate and acrylonitrile. The copolymers may be used as protective layers in multilayer articles that include UV sensitive substrate materials. The multilayer articles may also include a silicone hardcoat.
摘要翻译：公开了包含衍生自α-亚甲基-γ-丁内酯，苯乙烯，甲基丙烯酸甲酯和丙烯腈的结构单元的共聚物。共聚物可以用作多层制品中的保护层，其中包括紫外线敏感的基材。多层制品还可以包括硅氧烷硬涂层。

57. 发明申请

US20100171078A1 ELECTRON-TRANSPORTING MATERIALS AND PROCESSES FOR MAKING THE SAME 有权
标题翻译：电子传输材料及其制造方法
公开(公告)号：US20100171078A1
公开(公告)日：2010-07-08
申请号：US12350594
申请日：2009-01-08
申请人： Kelly Scott Chichak , Qing Ye
发明人： Kelly Scott Chichak , Qing Ye
IPC分类号： C09K11/06 , C07D213/06
CPC分类号： C07D401/14
摘要： Compounds of formula I may be used in optoelectronic devices wherein R1 and R2 are, independently at each occurrence, H, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a is an integer ranging from 0-2; b is 1 or 2; c is an integer ranging from 0-4; and Ar1 and Ar2 are independently heteroaryl.
摘要翻译：式I化合物可以用于其中R 1和R 2在每次出现时独立地为H，C 1 -C 20脂族基团，C 3 -C 20芳族基团或C 3 -C 20脂环族基团的光电子器件; a是0-2的整数; b为1或2; c是0-4的整数; Ar 1和Ar 2独立地是杂芳基。

58. 发明申请

US20090143553A1 TULIPALIN COPOLYMERS 有权
标题翻译： TULIPALIN共聚物
公开(公告)号：US20090143553A1
公开(公告)日：2009-06-04
申请号：US12277373
申请日：2008-11-25
申请人： James Pickett , Qing Ye , Daniel Steiger
发明人： James Pickett , Qing Ye , Daniel Steiger
IPC分类号： C08F24/00
CPC分类号： B32B27/08 , B32B27/18 , B32B27/365 , B32B2270/00 , B32B2398/10 , B32B2398/20 , Y10T428/31507 , Y10T428/31663 , Y10T428/31667 , Y10T428/31855 , Y10T428/31909 , Y10T428/31928 , Y10T428/31931 , Y10T428/31935
摘要： Copolymers are disclosed comprising structural units derived from α-methylene-γ-butyrolactone, styrene, methyl methacrylate and acrylonitrile. The copolymers may be used as protective layers in multilayer articles that include UV sensitive substrate materials. The multilayer articles may also include a silicone hardcoat.
摘要翻译：公开了包含衍生自α-亚甲基-γ-丁内酯，苯乙烯，甲基丙烯酸甲酯和丙烯腈的结构单元的共聚物。共聚物可以用作多层制品中的保护层，其中包括紫外线敏感的基材。多层制品还可以包括硅氧烷硬涂层。

59. 发明申请

US20070043203A1 Copolyetherimides 有权
标题翻译：共聚酰亚胺
公开(公告)号：US20070043203A1
公开(公告)日：2007-02-22
申请号：US11210164
申请日：2005-08-22
申请人： Qing Ye , David Hall , William Richards , Daniel Brunelle , Havva Acar
发明人： Qing Ye , David Hall , William Richards , Daniel Brunelle , Havva Acar
IPC分类号： C08G69/08
CPC分类号： C08G73/1046 , C08G73/124
摘要： Copolyetherimides compositions having high glass transition temperatures and outstanding ductility are presented. The copolyetherimides having Mw of at least 40,000 comprising isomeric bis(phthalimide) structural units within a relatively narrow range of isomer proportions exhibited Tgs of at least 240° C. and outstanding Notched Izod values. The copolyetherimides comprise oxydianiline residues and structural units of the formulas (I) and (II) (III). The copolyetherimides are characterized by a mole percentage of structural units derived from 4,4′-biphenol in a range from about 55% to about 85% of all bisphenol-derived structural units present in the copolyetherimide composition; a mole percentage of structural units derived from bisphenol A in a range from about 45% to about 15% of all bisphenol-derived structural units present in the copolyetherimide composition; and a total mole percentage of structural units derived from bisphenol A or 4,4′-biphenol of at least 95% of all bisphenol-derived structural units present in the copolyetherimide composition.
摘要翻译：提出了具有高玻璃化转变温度和优异延展性的共聚酰亚胺组合物。具有至少40,000的含有异构双（邻苯二甲酰亚胺）结构单元的异构体双组分（邻苯二甲酰亚胺）结构单元的共聚醚酰亚胺具有至少240℃的Tg和优异的缺口伊佐德值。共聚醚酰亚胺包括氧化二苯胺残基和式（I）和（II）（III）的结构单元。共聚醚酰亚胺的特征在于衍生自4,4'-联苯酚的结构单元的百分比在共聚醚酰亚胺组合物中存在的所有双酚衍生的结构单元的约55％至约85％的范围内; 来自双酚A的结构单元的摩尔百分比在存在于共聚醚酰亚胺组合物中的所有双酚衍生的结构单元的约45％至约15％的范围内; 并且衍生自双酚A或4,4'-联苯酚的结构单元的总摩尔百分比为存在于共聚醚酰亚胺组合物中的所有双酚衍生的结构单元的至少95％。

60. 发明授权

US06428818B1 Tea catechin formulations and processes for making same 失效
标题翻译：茶儿茶素制剂及其制备方法
公开(公告)号：US06428818B1
公开(公告)日：2002-08-06
申请号：US09640768
申请日：2000-08-17
申请人： Dorothy M. Morré , D. James Morré , Raymond Cooper , Howard Sun , Qing Ye
发明人： Dorothy M. Morré , D. James Morré , Raymond Cooper , Howard Sun , Qing Ye
IPC分类号： A61K3578
CPC分类号： A61K36/82 , A61K31/35 , A61K31/353 , A61K45/06 , A61K2300/00
摘要： The invention described herein encompasses methods and compositions of treating cancer or solid tumors comprising the administration of a therapeutically effective amount of catechins, a group of polyphenols found in green tea, to a mammal in need of such therapy. Compositions of catechins include but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), epigallocatechin (EGC). The unique compositions of the invention contain various combinations of the catechins with reduced levels of EGCg, alone or in combination with each other or other therapeutic agents and are used to treat primary and metastatic cancers in humans. The invention also encompasses the varying modes of administration of the therapeutic compounds.
摘要翻译：本文描述的发明包括治疗癌症或实体肿瘤的方法和组合物，包括向需要这种治疗的哺乳动物施用治疗有效量的儿茶素（一组在绿茶中发现的多酚）。儿茶素的组合物包括但不限于表没食子儿茶素没食子酸酯（EGCg），表儿茶素（EC），表儿茶素没食子酸酯（ECG），表没食子儿茶素（EGC））。本发明独特的组合物含有儿茶素类与EGCg水平的各种组合，单独或彼此组合或其它治疗剂，并用于治疗人类原发性和转移性癌症。本发明还包括治疗化合物的不同给药方式。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式